U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 536 records

Showing results for "statin".
Users also searched for: statin

  1. Disposition of Comments for Interventions To Improve Cardiovascular Risk Factors in People With Serious Mental Illness (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_disposition-comments.pdf
    April 22, 2013 - screening and monitoring of measures such as weight and blood pressure and a potentially increase role in statin

  2. Preparing for Ambulatory Computerized Prescriber Order Entry by Evaluating Preimplementation Medication Errors (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Devine.pdf
    July 01, 2003 - prior to instituting therapy with hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase inhibitor (statin … included in the Laboratory Harm Table, whereas the ongoing monitoring of a lipid panel to assess statin

  3. JAMA JATS (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/UA7cEG8wH4xh8-fr7Lfw9q
    September 18, 2018 - screening for abnormal blood glucose levels and type 2 diabetes, screening for high blood pressure, statin … screening for abnor- mal blood glucose levels and type 2 diabetes,13 screening for high blood pressure,14 statin … Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task

  4. Improving Healthcare Safety by Enhancing Medication Safety (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/highlights/ps-project-highlights-medication-safety.pdf
    April 30, 2025 - - 3A4 substrate versus a statin non-3A4 substrate with CYP3A4 inhibitor concomitancy. … evaluate the nonsignificant yet increased muscle toxicity interaction ratio observed for highly potent statin … dosages and within 6 months after statin initiation. … However, the overall results show no evidence of increased hazard of statin- related adverse events based … on statin metabolism.

  5. Slide 1

    effectivehealthcare.ahrq.gov/sites/default/files/study-design-considerations-chapter-2.pptx
    January 01, 2013 - Statin adherence and risk of accidents: a cautionary tale. Circulation 2009 Apr 21;119(15):2051-7. … The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in

  6. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49583/psn-pdf
    April 01, 2009 - for markers of cardiac injury was begun, and he was treated with a beta- blocker, enoxaparin, and a statin

  7. Evidence Report on the (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
    November 01, 2010 - Evidence Report on the Source: www.effectivehealthcare.ahrq.gov Published Online: July 28, 2010 Evidence-based Practice Center Systematic Review Protocol Project Title: Screening for and Management of Chronic Kidney Disease Stages 1-3 I. Background and Objectives for the Systematic Review T…

  8. Methods Guide Atkins (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
    January 01, 2011 - For example, the individual trials of statin drugs to treat high cholesterol each selected specific … of differing risks, nationalities, and underlying conditions provides evidence that the benefits of statin

  9. Methods-Guidance-Applicability Methods (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-applicability_methods.pdf
    January 01, 2011 - For example, the individual trials of statin drugs to treat high cholesterol each selected specific … of differing risks, nationalities, and underlying conditions provides evidence that the benefits of statin

  10. Encoding and Processing Patient Allergy Information in EHRs - Final Report (pdf file)

    digital.ahrq.gov/sites/default/files/docs/citation/r01hs022728-zhou-final-report-2018.pdf
    January 01, 2018 - Encoding and Processing Patient Allergy Information in EHRs - Final Report AHRQ Grant Final Progress Report Title of Project: Encoding and Processing Patient Allergy Information in EHRs Principle Inve…

  11. Evidence-based Practice Center Systematic Review Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb-disposition.pdf
    March 10, 2010 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: March 10, 2010 Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors…

  12. Federal Interagency Workgroup: Improving Diagnostic Safety and Quality in Healthcare: March 2024 Meeting (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/topics/dx-safety-workgroup-meeting-notes-mar2024.pdf
    July 26, 2024 - Federal Interagency Workgroup: Improving Diagnostic Safety and Quality in Healthcare: March 2024 Meeting Federal Interagency Workgroup: Improving Diagnostic Safety and Quality in Healthcare March 2024 Meeting Workgroup Goal: Established by Senate Report 115-150. The Senate Committee on Appropriations request…

  13. Enhancing Clinical Decision Support Applications for Community Pharmacist-Delivered Medication Therapy Management - Final Report (pdf file)

    digital.ahrq.gov/sites/default/files/docs/citation/r21hs025005-snyder-final-report-2019.pdf
    January 01, 2019 - Targeted by Alert (number of alerts evaluated) Indication 5 Need for ACE/ARBb therapy (2) Need for statin … 5 Drug-drug interaction to reduce plasma concentration of immunosuppressant drug (1) Sub-optimal statin … anti-diabetic) non-adherence (6) Cost 2 Cost-savings opportunity through switch to alternative drug (statin

  14. Enhanced Medical Histories: A Guide to Implementation in a Health Information Exchange (pdf file)

    digital.ahrq.gov/sites/default/files/docs/citation/EnhancedMedHistoriesImplementationGuide.pdf
    November 01, 2011 - for liver enzyme elevation) • NSAID (Nonsteroidal Anti-inflammatory Drug) • Potassium Supplement • Statin … < 0.3 TSH > 6 K Supplement Potassium > 5.5 Metformin Creatinine > 1.4 NSAID Creatinine > 2.0 Statin … Levothyroxine TSH: none found in past 12 months Anticonvulsant Serum drug level: none found in past 12 months Statin

  15. EvidenceNow Practice Survey Codebook: Practice Demographics (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/survey-codebook-demographics.pdf
    June 02, 2025 - practice uses clinical guidelines for management of patients at risk for cardiovascular disease (e.g., statin

  16. Archived: Evidence Summary: Diabetes Mellitus (Type 2) in Adults: Screening, 2003 | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/diabetes-mellitus-type-2-in-adults-screening-2003
    February 03, 2003 - but not nondiabetic persons with LDL cholesterol levels below 3.2 mmol/L (<125 mg/dL) benefited from statin … treatment. 107 A recent large study of statin treatment that included diabetic persons without established … the most effective target for diabetic persons is LDL cholesterol levels (which might lead to initial statin

  17. Section 8: The Care Management Evidence Base | Agency for Healthcare Research and Quality

    www.ahrq.gov/patient-safety/settings/long-term-care/resource/hcbs/medicaidmgmt/mm8.html
    October 01, 2014 - Designing and Implementing Medicaid Disease and Care Management Programs Section 8: The Care Management Evidence Base Previous Page Next Page Table of Contents Designing and Implementing Medicaid Disease and Care Management Programs Introduction Section 1: Planning a Care Management Program Se…

  18. Eptifibatide Epilogue | PSNet

    psnet.ahrq.gov/web-mm/eptifibatide-epilogue
    March 04, 2011 - for markers of cardiac injury was begun, and he was treated with a beta-blocker, enoxaparin, and a statin

  19. Slide 1

    effectivehealthcare.ahrq.gov/sites/default/files/exposure-definition-and-measurement_chapter-4.pptx
    January 01, 2013 - Slide 1 Exposure Definition and Measurement in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Exposure Definition and Measurement in Observational Comparative Effectiveness Research This slide set is based on a user guide titled Develop…

  20. Methods Guide for Comparative Effectiveness Reviews - Expanded Guidance on Selected Quantitative Synthesis Topics (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/quantitative-synthesis-expanded-methods_methods.pdf
    March 01, 2013 - Methods Guide for Comparative Effectiveness Reviews - Expanded Guidance on Selected Quantitative Synthesis Topics Methods Guide for Comparative Effectiveness Reviews Expanded Guidance on Selected Quantitative Synthesis Topics ii This report is based on research conducted by the Tufts…
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

www.uspreventiveservicestaskforce.org (128)

effectivehealthcare.ahrq.gov (123)

www.ahrq.gov (114)

digital.ahrq.gov (65)

cds.ahrq.gov (53)

psnet.ahrq.gov (44)

cdsic.ahrq.gov (4)

meps.ahrq.gov (3)

hcup-us.ahrq.gov (2)